CSIMarket
 
Davita Inc   (NYSE: DVA)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Davita Inc's Customers Performance

DVA



 
DVA's Source of Revenues Davita Inc's Corporate Customers have recorded an increase in their cost of revenue by 13.61 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 17.59 %. During the corresponding time, Davita Inc recorded a revenue increase by 5.17 % year on year, sequentially revenue grew by 4.06 %. While revenue at the Davita Inc 's corporate clients recorded rose by 3.6 % year on year, sequentially revenue grew by 2.28 %.

List of DVA Customers




Davita Inc's Customers have recorded an increase in their cost of revenue by 13.61 % in the 2 quarter 2026 year on year, sequentially costs of revenue grew by 17.59 %, for the same period Davita Inc recorded revenue increase by 5.17 % year on year, sequentially revenue grew by 4.06 %.

List of DVA Customers

Davita Inc's Business Units
Elimination of interrevenues    -0.7 % of total Revenue
Medicare and Medicare Advantage    49.05 % of total Revenue
Medicaid and Managed Medicaid    6.23 % of total Revenue
Other Government Payors    9.99 % of total Revenue
Commercial Payors    31.15 % of total Revenue
Other    0.99 % of total Revenue
U S Dialysis And Related Lab Services    85.53 % of total Revenue
U S Dialysis And Related Lab Services Elimination of interrevenues    -0.6 % of total Revenue
U S Dialysis And Related Lab Services Medicare and Medicare Advantage    49.05 % of total Revenue
U S Dialysis And Related Lab Services Medicaid and Managed Medicaid    6.23 % of total Revenue
U S Dialysis And Related Lab Services Other Government Payors    2.72 % of total Revenue
U S Dialysis And Related Lab Services Commercial Payors    27.94 % of total Revenue
U S Dialysis And Related Lab Services Other    0.18 % of total Revenue
Other Segment    14.47 % of total Revenue
Other Elimination of interrevenues    -0.1 % of total Revenue
Other Medicare and Medicare Advantage    3.18 % of total Revenue
Other Other Government Payors    7.27 % of total Revenue
Other Commercial Payors    3.21 % of total Revenue
Other Other    0.81 % of total Revenue
U S Dialysis And Related Lab Services with Intersegment    86.13 % of total Revenue
U S Dialysis And Related Lab Services with InterExternal Sources    85.34 % of total Revenue
U S Dialysis And Related Lab Services with InterIntersubEliminations    0.6 % of total Revenue
Other with Intersegment    14.57 % of total Revenue
Other with InterIntersubEliminations    0.1 % of total Revenue
InterElimination    -0.7 % of total Revenue
InterElimination U S Dialysis And Related Lab Services    -0.6 % of total Revenue
InterElimination Other Segment    -0.1 % of total Revenue




   
Customers Net Income grew in Q2 by Customers Net margin grew to
65.84 % 4.84 %
Customers Net Income grew in Q2 by 65.84 %


Customers Net margin grew to 4.84 %



Davita Inc's Customers, Q2 2026 Revenue Growth By Industry
Customers in Accident & Health Insurance Industry      2.68 %
Customers in Life Insurance Industry      10.46 %
Customers in Property & Casualty Insurance Industry      11.73 %
Customers in Miscellaneous Financial Services Industry -6.27 %   
Customers in Healthcare Facilities Industry      6.77 %
     
• Customers Valuation • Customers Mgmt. Effect.


Davita Inc's Comment on Sales, Marketing and Customers



On average, dialysis-related payment rates from commercial payors are significantly higher than Medicare, Medicaid and other government program payment rates, and therefore the percentage of commercial patients to total patients represents a major driver of our total average dialysis revenue per treatment. The percentage of commercial patients covered under contracted plans as compared to commercial patients with out-of-network providers continued to increase and can also significantly affect our average dialysis revenue per treatment since commercial payment rates for patients with out-of-network providers are on average higher than in-network payment rates that are covered under contracted plans. In 2013, the growth of our government-based patients continued to outpace the growth of our commercial patients, which has been a trend that we have experienced for the past several years. We believe the growth in our government-based patients is driven primarily by improved mortality and the current economic environment that has resulted in a decrease in the number of individuals that are covered under commercial insurance plans. This trend has negatively impacted our average dialysis revenue per treatment over the last several years as a result of receiving a larger proportion of our revenue from government-based payors, such as Medicare, that reimburse us at lower payment rates.

HCP capitated revenues consist primarily of fees for medical services provided under capitated contracts with various health plans or under FFS arrangements with privately insured individuals. Capitation revenue derived from health plans typically results from either (i) premium payments by CMS to HCP’s health plan customers under Medicare Advantage with respect to seniors, disabled and other eligible persons (which are referred to herein as HCP’s senior membership), (ii) premium payments by state governments to HCP’s health plan customers under Medicaid managed care programs (which are referred to herein as HCP’s Medicaid membership), and (iii) premium payments from public and private employers and individuals to HCP’s health plan customers with respect to their employees (which are referred to herein as HCP’s commercial membership). Capitation payments under health plan contracts are made monthly based on the number of enrollees selecting an HCP associated group physician employed or associated with one of HCP’s medical group entities as their primary health care provider. The amount of monthly capitation HCP receives from health plans on behalf of a member generally does not vary during a given calendar year, regardless of the level of actual medical services utilized by the member. Due to differing state laws affecting health care entities, HCP’s capitation contracts fall into two general categories. As described in more detail below, in central Florida, southern Nevada, New Mexico and Arizona, HCP utilizes a global capitation model in which it assumes the financial responsibility for both professional (physician) and institutional (or hospital) services for covered benefits. In 2013, in southern California, HCP utilized variants of a different model for capitation under which it is directly financially responsible for covered professional services, but indirectly financially responsible for covered institutional expenses. See below for further discussion regarding changes to HCP’s revenue recognition for hospital services in 2014. HCP’s associated medical groups also receive specified incentive payments from health plans based on specified performance and quality criteria. These amounts are accrued when earned, and the amounts can be reasonably estimated.






Davita Inc’s Comment on Sales, Marketing and Customers


On average, dialysis-related payment rates from commercial payors are significantly higher than Medicare, Medicaid and other government program payment rates, and therefore the percentage of commercial patients to total patients represents a major driver of our total average dialysis revenue per treatment. The percentage of commercial patients covered under contracted plans as compared to commercial patients with out-of-network providers continued to increase and can also significantly affect our average dialysis revenue per treatment since commercial payment rates for patients with out-of-network providers are on average higher than in-network payment rates that are covered under contracted plans. In 2013, the growth of our government-based patients continued to outpace the growth of our commercial patients, which has been a trend that we have experienced for the past several years. We believe the growth in our government-based patients is driven primarily by improved mortality and the current economic environment that has resulted in a decrease in the number of individuals that are covered under commercial insurance plans. This trend has negatively impacted our average dialysis revenue per treatment over the last several years as a result of receiving a larger proportion of our revenue from government-based payors, such as Medicare, that reimburse us at lower payment rates.

HCP capitated revenues consist primarily of fees for medical services provided under capitated contracts with various health plans or under FFS arrangements with privately insured individuals. Capitation revenue derived from health plans typically results from either (i) premium payments by CMS to HCP’s health plan customers under Medicare Advantage with respect to seniors, disabled and other eligible persons (which are referred to herein as HCP’s senior membership), (ii) premium payments by state governments to HCP’s health plan customers under Medicaid managed care programs (which are referred to herein as HCP’s Medicaid membership), and (iii) premium payments from public and private employers and individuals to HCP’s health plan customers with respect to their employees (which are referred to herein as HCP’s commercial membership). Capitation payments under health plan contracts are made monthly based on the number of enrollees selecting an HCP associated group physician employed or associated with one of HCP’s medical group entities as their primary health care provider. The amount of monthly capitation HCP receives from health plans on behalf of a member generally does not vary during a given calendar year, regardless of the level of actual medical services utilized by the member. Due to differing state laws affecting health care entities, HCP’s capitation contracts fall into two general categories. As described in more detail below, in central Florida, southern Nevada, New Mexico and Arizona, HCP utilizes a global capitation model in which it assumes the financial responsibility for both professional (physician) and institutional (or hospital) services for covered benefits. In 2013, in southern California, HCP utilized variants of a different model for capitation under which it is directly financially responsible for covered professional services, but indirectly financially responsible for covered institutional expenses. See below for further discussion regarding changes to HCP’s revenue recognition for hospital services in 2014. HCP’s associated medical groups also receive specified incentive payments from health plans based on specified performance and quality criteria. These amounts are accrued when earned, and the amounts can be reasonably estimated.










DVA's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Davita Inc 12,166.22 13,835.09 1,121.54 78,000
Aflac Incorporated 58,116.19 17,164.00 3,646.00 12,716
Centene Corporation 30,900.77 198,101.00 -6,452.00 61,100
Cno Financial Group Inc 5,231.86 4,512.90 245.50 3,300
Futu Holdings Ltd 133,128.02 2,935.37 1,452.07 202
Molina Healthcare Inc 9,939.12 45,075.00 188.00 19,000
SUBTOTAL 1,889,492.57 2,981,795.07 73,885.55 1,843,932
14 more clients available

Sign in to see all corporate customers for Davita Inc .

Sources: Davita Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Davita Inc’s corporate clients.
For your research, we’ve provided 9 tables on Davita Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.